IKZF1/3 and CRL4CRBN E3 ubiquitin ligase mutations and resistance to immunomodulatory drugs in multiple myeloma
Barrio S, Munawar U, Zhu YX, Giesen N, Shi CX, Da Via M, Sanchez R, Bruins L, Demler T, Mueller N, Haertle L, Garitano A, Steinbrunn T, Danhof S, Cuenca I, Barrio-Garcia C, Braggio E, Rosenwald A, Martinez-Lopez J, Rasche L, Raab MS, Stewart AK, Einsele H, Stuehmer T, Kortuem KM (2020)
Publication Type: Journal article
Publication year: 2020
Journal
Book Volume: 105
Pages Range: E237-E241
Journal Issue: 5
DOI: 10.3324/HAEMATOL.2019.217943
Involved external institutions
Universitätsklinikum Würzburg
Germany (DE)
Universidad Complutense de Madrid (UCM)
Spain (ES)
Mayo Clinic
United States (USA) (US)
Universitätsklinikum Heidelberg
Germany (DE)
Ludwig-Maximilians-Universität (LMU)
Germany (DE)
Julius-Maximilians-Universität Würzburg
Germany (DE)
Germany (DE)
Universidad Complutense de Madrid (UCM)
Spain (ES)
Mayo Clinic
United States (USA) (US)
Universitätsklinikum Heidelberg
Germany (DE)
Ludwig-Maximilians-Universität (LMU)
Germany (DE)
Julius-Maximilians-Universität Würzburg
Germany (DE)
How to cite
APA:
Barrio, S., Munawar, U., Zhu, Y.X., Giesen, N., Shi, C.-X., Da Via, M.,... Kortuem, K.M. (2020). IKZF1/3 and CRL4CRBN E3 ubiquitin ligase mutations and resistance to immunomodulatory drugs in multiple myeloma. Haematologica, 105(5), E237-E241. https://doi.org/10.3324/HAEMATOL.2019.217943
MLA:
Barrio, Santiago, et al. "IKZF1/3 and CRL4CRBN E3 ubiquitin ligase mutations and resistance to immunomodulatory drugs in multiple myeloma." Haematologica 105.5 (2020): E237-E241.
BibTeX: Download